SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-18-047824
Filing Date
2018-08-21
Accepted
2018-08-21 18:07:29
Documents
1
Period of Report
2017-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4351
  Complete submission text file 0001209191-18-047824.txt   5912
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Issuer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address
Riehle J Nick (Reporting) CIK: 0001316746 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38112 | Film No.: 181031106